Nolpaza Control 20 mg. 14 tablets
Nolpaza Control contains the active substance pantoprazole, which blocks the "pump" that produces hydrochloric acid in the stomach. In this way the product reduces acidity in your stomach.
Nalpase control is used to treat short-term symptoms of gastric reflux (such as stomach acid and acid reflux) in adults.
Gallbladder reflux is a return of acid stomach contents into the esophagus, which can cause inflammation or pain. This can lead to symptoms such as a feeling of burning chest pain reaching the throat (heartburn) and an unpleasant sour taste in the mouth (sour boils).
You may feel relief from the symptoms of acid reflux and heartburn after only one day of treatment with Nalpase control, but this medicine is not intended to result in immediate relief. You may need to take the tablets for 2-3 consecutive days to relieve the symptoms.
If after 2 weeks you do not feel better or your condition gets worse, you should seek medical attention.
2. What should you know before using Nolpaza Control
Do not take Nolpaza Control
if you are allergic (hypersensitive) to pantoprazole or any of the other ingredients of this medicine (listed in section 6),
if you are taking medicines containing atazanavir (to treat HIV infection). Warnings and precautions
Talk to your doctor or pharmacist before taking Nopalase Control.
Tell your doctor immediately if:
have been treated prolonged for gastric or stomach upset for 4 weeks or more
you are over 55 years of age and are taking daily without prescription a medicine against indigestion
you are over 55 years old and have new or recently changed symptoms
have had a stomach ulcer or have experienced a stomach operation
have liver problems or jaundice (yellowing of the skin or eyes)
regularly visit your doctor for serious complaints or illnesses
you should conduct an endoscopic examination or a breath test called the C-ureas test
you have ever experienced a skin reaction after treatment with a drug like Nalapa control that reduces stomach acid,
you have to do a certain type of blood test (Chrombone A).
If you get a rash on the skin, especially in areas exposed to the sun, tell your doctor as soon as possible, as you may need to stop treatment with Nalapa control. Do not forget to mention all the other adverse effects, such as joint pain.
Tell your doctor immediately if you notice any of the following symptoms before or after taking this medicine that may indicate another more serious condition:
unwanted weight loss (unrelated to diet or physical exertion) vomiting, especially if it is repeated
vomiting of blood; may appear to be a sediment of coffee in the vomited fabric if you notice blood in your stools that may look black or resinous
difficulty or pain when swallowed look pale or feel faint (anemia) chest pain stomach pain
severe and / or prolonged diarrhea because Nalapa control is associated with a slightly increased incidence of infectious diarrhea.
Your doctor may decide that you need further research.
If you are going to have blood tests, tell your doctor that you are taking this medicine.
You may feel relieving the symptoms of acid reflux and heartburn after just one day of treatment with Nalpase control, but this medicine is not intended to result in immediate relief. You should not take it as a prophylactic treatment.
If you have had recurrent symptoms of heartburn or indigestion, do not forget to visit your doctor regularly.
Children and adolescents
Nopalase control should not be used in children and adolescents below 18 years of age due to a lack of safety data in this young age group.
Other medicines and Nolpaza Control
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Nalpase control may prevent other medicines from acting properly. Tell your doctor or pharmacist if you are taking any other medicines containing any of the following active substances:
ketoconazole (used to treat fungal infections);
warfarin and fenprocoumon (used to dilute blood and prevent it
clotting). You may need extra blood
atazanavir (used to treat HIV infection). You should not take Nopalase Control if you are being treated with atazanavir.
methotrexate (used to treat rheumatoid arthritis, psoriasis and cancer) - if you are taking methotrexate, your doctor may temporarily stop your treatment with Nalapa as pantoprazole may increase methotrexate levels
3. How to take Nolpaza Control?
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Take one tablet a day. Do not exceed the recommended dose of 20 mg pantoprazole per day.
You should take this medicine for at least 2-3 consecutive days. Stop taking Nalpase Control when your symptoms completely disappear. You may feel relieving the symptoms of acid reflux and heartburn after just one day of treatment with Nalpase control, but this medicine is not intended to result in immediate relief.
If you do not have symptoms after taking the medicine for 2 consecutive weeks, you should consult your doctor.
Do not take Nolpaza Control tablets for more than 4 weeks without consulting your doctor.
Take the tablet before a meal, at the same time each day. You should swallow the tablet whole with water. Do not chew or break the tablet.
If you take more than the necessary dose of Nolpaza Control
Tell your doctor or pharmacist immediately. If possible carry the medicine and this leaflet with you. There are no known symptoms of overdose.
If you forget to take Nolpaza Control
Do not take a double dose to make up for the missed dose. Take your next dose the next day at the usual time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Tell your doctor immediately or contact the emergency department of the nearest hospital if you experience any of the following serious side effects. Stop taking the medicine immediately and take the package leaflet and / or the tablets with you.
Serious allergic reactions (rare: may affect up to 1 in 1,000 people):
Hypersensitivity reactions, so-called anaphylactic reactions, anaphylactic shock and angioedema. Typical symptoms are swelling of the face, lips, tongue and / or throat, which may cause difficulty in swallowing and breathing, urticaria (hives), severe dizziness, severe heartbeat and abundant sweating. Serious skin reactions (frequency not known: frequency can not be estimated from the available data): swelling with swelling, blistering or scaling; loss of skin and bleeding around the eyes, nose, mouth or genitals and rapid worsening of the general condition or rash when exposed to sunlight.
Other serious reactions (not known): yellowing of the skin and eyes (due to serious liver damage) or kidney problems such as painful urination or low back pain with fever.
Other side effects include:
Common side effects (may affect up to 1 in 10 people): benign polyps in the stomach
Uncommon side effects (may affect up to 1 in 100 people): headache; dizziness; diarrhea; nausea, vomiting; abdominal swelling and large amounts of gas; constipation; dry mouth; colic and discomfort; skin rash or urticaria; itching; feeling weak, feeling tired or feeling unwell; sleep disturbance; increased hepatic enzymes in blood tests.
Rare side effects (may affect up to 1 in 1,000 people): disorder or complete lack of taste, visual disturbances such as blurred vision, joint pain; muscle pain; changes in body weight; increased body temperature; swelling of the limbs; allergic reactions; depression; increased bilirubin and fat in the blood (found in blood tests). Breast augmentation in men; high temperature and a sharp decrease in circulating granulocytes, white blood cells (observed in blood tests).
Very rare side effects (may affect up to 1 in 10,000 people): disorientation; decreasing the number of platelets, which may cause bleeding and bruising more pronounced than usual; reducing the number of white blood cells, which may lead to more frequent infections; accompanied by an abnormal reduction in the number of red and white blood cells, as well as platelets (observed in blood tests).
Not known (frequency can not be estimated from the available data): hallucinations, confusion (particularly in patients with a history of these symptoms); decreased blood sodium levels, decreased magnesium levels in the blood; decreased blood calcium levels, decreased levels of potassium in the blood, tingling or numbness of the arms or legs, muscle spasms, rash that may be accompanied by joint pain.
How to store Nolpaza Control?
Keep out of the reach and sight of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
Store in the original package in order to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of your unnecessary medicines. These measures will help to protect the environment.
6. Package Contents and Additional Information
What contains Nolpaza Control
The active substance is pantoprazole. Each tablet contains 20 mg of pantoprazole (such as pantoprazole sodium sesquihydrate).
The other ingredients are mannitol, crospovidone (type B), anhydrous sodium carbonate, sorbitol (E420), and calcium stearate in the tablet core and hypromellose, povidone, titanium dioxide (E171), yellow iron oxide (E172), propylene glycol, methacrylic acid-ethyl acrylate (1: 1), 30 percent dispersion, sodium lauryl sulfate, polysorbate 80, macrogol 6000 and talc in the film coating.
What Nalpaza looks like and what the package contains
20 mg gastro-resistant tablets are light yellowish-brown, oval (3 mm x 9 mm) slightly biconvex film-coated tablets.
Nolpaza Control is available in 7 and 14 gastro-resistant tablets in a blister pack of 7 or 14 tablets.
Not all pack sizes may be marketed.